// App-Quantinova.ai

3054 : German Hodgkin Study Group Phase I Trial Of Doxorubicin, Vinblastine, Dacarbazine, and Lenalidomide (AVD-Rev) For Older Hodgkin Lymphoma Patients

Researchers

Presenter

  • Boris Boll

Principal Investigators

  • Annette Plutschow

  • Michael Fuchs

  • Martin Sokler

  • Andreas Engert

  • Peter Borchmann

  • Dennis A. Eichenauer

  • Indra Thielen

  • Bastian von Tresckow

  • Karolin Behringer

  • Johannes Atta

  • Michael Pfreundschuh

  • Michaela Feuring-Buske

  • Martin Vogelhuber

Medical Centers

  • Abteilung Innere Medizin II, Universitatsklinikum Tubingen, Tubingen, Germany

  • First Department of Internal Medicine, German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany

  • Internal Medicine I, University of Cologne, Cologne, Germany

  • First Department of Internal Medicine, German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany

  • Oncology Hematology, Ubiversity Hospital Regensburg, Regensburg, Germany

  • German Hodgkin Study Group (GHSG), Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany

  • Department of Internal Medicine, University Hospital of Ulm, Ulm, Germany

  • Internal Medicine I, Saarland University Medical School, Homburg, Germany

  • German Hodgkin Study Group (GHSG), Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany

  • Cologne, Germany, German Hodgkin Study Group GHSG, Cologne, Germany

  • Department of Hematology/Oncology, Goethe-University Hospital Frankfurt, Frankfurt Am Main, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

  • Thrombocytopenia

  • Venous thrombosis

  • Lymphomas

Biomarkers

  • Circulating tumor cells

  • Granulocyte colony-stimulating factor

Drug/Treatment

  • Lenalidomide

  • dacarbazine Intravenous

  • Vinblastine

  • Doxorubicin

  • Bleomycin

  • Heparin

  • Filgrastim

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved